Skip to main content

Institutional intelligence for Bannari Amman Sugars Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Tracked super investors holding ≥1%

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters58.70%
  • FII0.27%
  • Retail & others41.03%
  • Super Investors 2.59%(subset)
  • 1% Club 20.80%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

58.70%5 named
HolderStakeSharesValue (₹ Cr)
44.00%55,17,841₹1.91k Cr
8.42%10,56,232₹366.3 Cr
3.82%4,79,349₹166.2 Cr
1.44%1,80,658₹62.6 Cr
1.01%1,26,196₹43.8 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

41.03%

SEBI requires naming only shareholders with ≥1% stake. The remaining 41.03% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

20.80%7 named
HolderStakeSharesValue (₹ Cr)
5.53%6,92,970₹240.3 Cr
4.52%5,66,244₹196.4 Cr
2.67%3,35,000₹116.2 Cr
2.57%3,21,673₹111.5 Cr
2.31%2,90,241₹100.7 Cr
1.90%2,38,000₹82.5 Cr
1.30%1,63,180₹56.6 Cr

Super Investors

Curated tracked investor profiles

2.59%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as Nemish Shah2.59%3,25,000₹112.7 Cr

FII / FPI

Foreign portfolio investors

0.27%No names

No named holders ≥1% in this bucket.

DII (other)

Insurance, banks, AIF, other domestic institutions

No names

No named holders ≥1% in this bucket.

Mutual Funds

Domestic mutual funds & UTI

No names

No named holders ≥1% in this bucket.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.